| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/11/2001 | EP1089984A1 Non-yellowing para-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers |
| 04/11/2001 | EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 04/11/2001 | EP1089662A1 Improvements in or relating to cardiac imaging |
| 04/11/2001 | CN1291093A Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 04/11/2001 | CA2322995A1 Process for the preparation of pyrazolo ¬4,3-d|pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof |
| 04/10/2001 | US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders |
| 04/10/2001 | US6214360 Pharmaceutical composition |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2000030668A9 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 04/05/2001 | US20010000144 Symptomatic relief of allergic reactions |
| 04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
| 04/04/2001 | EP1088555A1 Sustained-release preparation |
| 04/04/2001 | EP1087976A1 Polymorphic clopidogrel hydrogenesulphate form |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP1087764A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 04/04/2001 | CN1290258A Arylpiperazines having activity at the serotnin 1A receptor |
| 04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
| 04/03/2001 | US6211186 Polyoxyalkylene glycol modified with n-heterocycle derivative with amidine or guanidine group; diaper rash, obesity, acne, periodontal disease, contraceptives; protease and lipase inhibitors |
| 04/03/2001 | US6211171 Administering tricyclic amitriptyline and desipramine to treat neuropathic pain |
| 04/03/2001 | US6211151 Peptides with organo-protective activity, a process for preparation thereof and their use in therapy |
| 04/03/2001 | US6210695 Leave-on antimicrobial compositions |
| 03/29/2001 | WO2001021596A1 Quinazoline derivatives and their use as pharmaceuticals |
| 03/29/2001 | WO2001021594A1 Quinazoline compounds and pharmaceutical compositions containing them |
| 03/29/2001 | WO2000051576A3 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 03/29/2001 | CA2384291A1 Quinazoline derivatives and their use as pharmaceuticals |
| 03/29/2001 | CA2384282A1 Quinazoline compounds and pharmaceutical compositions containing them |
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1085886A1 Protecting neurons from ischemia |
| 03/28/2001 | EP1085883A1 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases |
| 03/28/2001 | EP1085867A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 03/28/2001 | EP0831897B1 In ovo vaccination against coccidiosis |
| 03/28/2001 | EP0714281B1 Deodorant composition containing acetyl hexamethyl tetralin (tonalide) |
| 03/28/2001 | CN1289338A 2-(purin-9-yl)-tetahydrofuran-3,4-diol derivatives |
| 03/28/2001 | CN1289251A synergistic mixtures of natural products |
| 03/27/2001 | US6207669 In treatment of cancer and psoriasis |
| 03/27/2001 | US6207188 Omeprazole sodium salt |
| 03/27/2001 | US6207164 Plant extracts |
| 03/27/2001 | US6207142 Compositions containing an antifungal and a cationic agent |
| 03/27/2001 | US6207134 Ultrafine lightly coated superparamagnetic particles for MRI |
| 03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | WO2001019320A2 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | WO2000030607A8 PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a |
| 03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs |
| 03/21/2001 | EP1084708A1 A process of powder for bath from natural plants |
| 03/21/2001 | EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 03/21/2001 | EP1084104A1 Nitric oxide synthase inhibitors |
| 03/21/2001 | EP1083934A2 Gene therapy method |
| 03/21/2001 | EP1083914A1 Treatment of arthritis and other similar conditions |
| 03/21/2001 | EP1083879A1 Methods and devices for providing prolonged drug therapy |
| 03/21/2001 | EP1083870A1 Dentifrice composition containing encapsulated reactive ingredients |
| 03/21/2001 | EP1083856A1 Topical transdermal treatments |
| 03/21/2001 | EP1083790A1 Retarding formulations of active substances used for plant protection |
| 03/21/2001 | EP0910330A4 Hair dye compositions and process |
| 03/21/2001 | CN1288458A Triazepinones, process for their prepn. and their therapeutic application |
| 03/20/2001 | US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols |
| 03/20/2001 | US6203798 Lyme disease diagnosis and vaccines; genetic engineering |
| 03/20/2001 | US6203796 Oregano-based therapeutic composition |
| 03/20/2001 | US6203784 Hectorite clay, calcium hydroxide, cetostearyl alcohol, polyoxyethylene glycol fatty alcohol, urea, and potassium thioglycolate; rinsability |
| 03/15/2001 | WO2001017976A1 Bis-sulfonamides |
| 03/15/2001 | WO2001017957A1 Prostaglandin e analogues |
| 03/15/2001 | WO2001017539A1 Herbal compositions for itchy or infected skin |
| 03/15/2001 | WO2001017504A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 03/15/2001 | US20010000038 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 03/15/2001 | CA2384148A1 Prostaglandin e analogues |
| 03/14/2001 | EP1082323A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082304A1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082299A1 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 03/14/2001 | EP1082093A1 Anti-germ attachment - composition |
| 03/14/2001 | CN1287484A Therapeutic formulation for administering tolterodine with controlled release |
| 03/14/2001 | CN1287483A Dyeing composition for keratinous fibres with a direct cationic colouring agent and a anionic surfactant |
| 03/14/2001 | CN1287482A Dyeing composition for keratinous fibres with direct cationic colouring agent and a quaternary ammonium salt |
| 03/13/2001 | US6201027 Substituted β diketones and their use |
| 03/13/2001 | US6200548 Gas or air filled polymeric microballoons |
| 03/08/2001 | WO2001015732A1 Remedies for immunological diseases |
| 03/08/2001 | WO2001015701A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 03/08/2001 | WO2000076998B1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/08/2001 | WO2000057861A3 Use of cytidine derivatives for the treatment of leukaemia |
| 03/08/2001 | WO2000041546A9 Novel exendin agonist formulations and methods of administration thereof |
| 03/07/2001 | EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 03/07/2001 | EP1079860A1 Nicotine immunogen |
| 03/07/2001 | EP1079817A1 Pharmaceutical composition comprising d-chiro-inositol for improving insulin sensitivity and glucose metabolism |
| 03/07/2001 | EP1079794A1 Method and system for color customizing cosmetic mass products |
| 03/07/2001 | EP1041921A4 Preemptive prophylaxis of migraine device and method |
| 03/07/2001 | CN1286633A Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
| 03/07/2001 | CN1286622A High moisture toothpaste |
| 03/06/2001 | US6197306 Herbal composition for the treatment of chronic obstructive pulmonary disease, bronchitis and respiratory disorders and a process for preparing the same |
| 03/01/2001 | WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/01/2001 | WO2001014376A1 Novel spiro compounds |
| 03/01/2001 | WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 03/01/2001 | WO2001013953A2 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist |
| 03/01/2001 | WO2001013944A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 03/01/2001 | WO1998042379A3 Chemically and thermally stable norastemizole formulations |
| 03/01/2001 | CA2715683A1 Synergistic combination |
| 02/28/2001 | EP1078925A1 4-Phenylpiperidine compounds |
| 02/28/2001 | EP1078637A2 Composition for the treatment and prevention of nicotine addiction containing a nicotine receptor agonist and an anti-depressant or anti-anxiety drug |
| 02/28/2001 | EP1078631A1 Use of macrolide antibiotics for the treatment or prevention of coccidiosis |
| 02/28/2001 | EP1077984A1 2"-deoxy hygromycin derivatives |